Abbott has initiated a voluntary medical device correction for a number of FreeStyle Libre 3 sensors distributed in the United States during the first half of May 2024. The FreeStyle Libre 3 system ...
The Food and Drug Administration issued an “early alert” concerning FreeStyle Libre 3 and FreeStyle Libre Plus sensors used by people who have diabetes. The agency said Abbott Diabetes Care has sent a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Abbott issued a medical device correction for some ...
Diabetes remains one of the nation’s most prevalent and dangerous chronic conditions, affecting nearly 15% of U.S. adults and causing more than 100,000 deaths each year. As a response, the landscape ...
Abbott Diabetes Care has issued a recall and is warning patients to stop using certain glucose monitors following the deaths of seven people Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus ...
The U.S. Food and Drug Administration (FDA) is issuing an Early Alert for specific glucose monitoring systems because Abbott Diabetes Care recommends they be removed from the market. Certain FreeStyle ...
Some FreeStyle Libre 3 glucose sensors made by Abbott Diabetes Care may give incorrect low readings. The devices have been linked to potential deaths.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback